Novel strategies for enhanced detection of hemoglobinopathy carriers
Ended Project Grant Awarded Last action
- Award ID
- R43HL147785
- Recipient
-
Asuragen Incorporated UEI E8M9NXN4X4Y7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $217,726
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Texas, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,345 | |
| Amendment | $1,345 | |
| Amendment | -$5,372 | |
| Amendment | -$5,372 | |
| Amendment | -$5,372 | |
| Original award | $231,153 |
Quick answers
Who received award R43HL147785?
R43HL147785 was awarded to Asuragen Incorporated by National Heart Lung and Blood Institute (National Institutes of Health) on September 20, 2019.
How much is award R43HL147785 worth?
$217,726 has been obligated on R43HL147785.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award